A Phase II Study of Oxaliplatin, 5-Fluorouracil, Leucovorin, and High-Dose Capecitabine in Patients With Metastatic Colorectal Cancer

PURPOSE: Capecitabine has shown similar efficacy to 5-fluorouracil (5-FU); a regimen containing 2 weeks of capecitabine/oxaliplatin (CapOx) has demonstrated noninferiority to infusional 5-FU/oxaliplatin/leucovorin (FOLFOX) for the treatment of metastatic colorectal cancer (mCRC). This phase II study...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Lubner, Sam J., LoConte, Noelle K., Holen, Kyle D., Schelman, William, Thomas, James P., Jumonville, Alcee, Eickhoff, Jens C., Seo, Songwon, Mulkerin, Daniel L.
Format: Artigo
Idioma:Inglês
Publicat: 2010
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3058720/
https://ncbi.nlm.nih.gov/pubmed/20643620
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3816/CCC.2010.n.021
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars